These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18972410)

  • 1. Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis.
    Minasian C; Wallis C; Metcalfe C; Bush A
    Pediatr Pulmonol; 2008 Nov; 43(11):1078-1084. PubMed ID: 18972410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial.
    Minasian C; Wallis C; Metcalfe C; Bush A
    Thorax; 2010 Jan; 65(1):51-6. PubMed ID: 19996349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial.
    Teper A; Jaques A; Charlton B
    J Cyst Fibros; 2011 Jan; 10(1):1-8. PubMed ID: 20888307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline.
    Brannan JD; Anderson SD; Perry CP; Freed-Martens R; Lassig AR; Charlton B;
    Respir Res; 2005 Dec; 6(1):144. PubMed ID: 16336673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled mannitol for the treatment of cystic fibrosis.
    Hurt K; Bilton D
    Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannitol dry powder for inhalation: in patients with cystic fibrosis.
    Burness CB; Keating GM
    Drugs; 2012 Jul; 72(10):1411-21. PubMed ID: 22755516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
    Aitken ML; Bellon G; De Boeck K; Flume PA; Fox HG; Geller DE; Haarman EG; Hebestreit HU; Lapey A; Schou IM; Zuckerman JB; Charlton B;
    Am J Respir Crit Care Med; 2012 Mar; 185(6):645-52. PubMed ID: 22198974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.
    De Boeck K; Haarman E; Hull J; Lands LC; Moeller A; Munck A; Riethmüller J; Tiddens H; Volpi S; Leadbetter J; Charlton B; Malfroot A;
    J Cyst Fibros; 2017 May; 16(3):380-387. PubMed ID: 28258928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of inhaled dry powder mannitol on mucus and its clearance.
    Daviskas E; Rubin BK
    Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol.
    Anderson SD; Brannan J; Spring J; Spalding N; Rodwell LT; Chan K; Gonda I; Walsh A; Clark AR
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):758-65. PubMed ID: 9309990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study.
    Bilton D; Robinson P; Cooper P; Gallagher CG; Kolbe J; Fox H; Jaques A; Charlton B;
    Eur Respir J; 2011 Nov; 38(5):1071-80. PubMed ID: 21478216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
    Robinson M; Daviskas E; Eberl S; Baker J; Chan HK; Anderson SD; Bye PT
    Eur Respir J; 1999 Sep; 14(3):678-85. PubMed ID: 10543292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled mannitol improves lung function in cystic fibrosis.
    Jaques A; Daviskas E; Turton JA; McKay K; Cooper P; Stirling RG; Robertson CF; Bye PTP; LeSouëf PN; Shadbolt B; Anderson SD; Charlton B
    Chest; 2008 Jun; 133(6):1388-1396. PubMed ID: 18339790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled mannitol and cystic fibrosis. Unnecessary bronchial irritation.
    Prescrire Int; 2014 Apr; 23(148):89-91. PubMed ID: 24860889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Apparatus to Deliver Mannitol Powder for Bronchial Provocation in Children Under Six Years Old.
    Tang P; Leung SS; Hor E; Ruzycki CA; Carrigy NB; Finlay WH; Brannan JD; Devadason S; Anderson SD; Sly PD; Samnick K; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):452-61. PubMed ID: 25844950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeatability of bronchial responsiveness to mannitol dry powder in children with asthma.
    Barben J; Roberts M; Chew N; Carlin JB; Robertson CF
    Pediatr Pulmonol; 2003 Dec; 36(6):490-4. PubMed ID: 14618640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bronchial hyperreactivity with mannitol dry powder challenge test in a paediatric population with intermittent allergic asthma or allergic rhinitis.
    Decimo F; Capristo C; Amelio R; Maiello N; Capristo AF; Miraglia Del Giudice M
    Int J Immunopathol Pharmacol; 2011; 24(4):1069-74. PubMed ID: 22230412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannitol challenge does not confirm bronchial hyperreactivity in some histamine-responsive asthmatic children.
    Swiebocka EM; Siergiejko G; Siergiejko Z
    J Asthma; 2012 Oct; 49(8):817-21. PubMed ID: 22978308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled Dry Powder Mannitol Treatment in Pediatric Patients with Cystic Fibrosis: Evaluation of Clinical Data in a Real-World Setting.
    Duman I; Ünal G; Yilmaz AI; Güney AY; Durduran Y; Pekcan S
    Pediatr Allergy Immunol Pulmonol; 2022 Mar; 35(1):19-26. PubMed ID: 35285672
    [No Abstract]   [Full Text] [Related]  

  • 20. A pilot study of inhaled dry-powder mannitol during cystic fibrosis-related pulmonary exacerbation.
    Middleton A; Robinson PD; McKay K; Jaffe A; Selvadurai H
    Eur Respir J; 2015 Feb; 45(2):541-4. PubMed ID: 25359334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.